W
Werner Leber
Researcher at Queen Mary University of London
Publications - 21
Citations - 274
Werner Leber is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Cluster randomised controlled trial & Population. The author has an hindex of 7, co-authored 19 publications receiving 225 citations. Previous affiliations of Werner Leber include University of London.
Papers
More filters
Journal ArticleDOI
Explaining high and low performers in complex intervention trials: a new model based on diffusion of innovations theory.
TL;DR: An adaptation of the diffusion of innovations model was an effective analytical tool for retrospectively explaining high and low-performing practices in a complex intervention research trial.
Journal ArticleDOI
Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial.
Werner Leber,Heather McMullen,Jane Anderson,Nadine Marlin,Andreia Santos,Stephen Bremner,Kambiz Boomla,Sally Kerry,D Millett,Sifiso Mguni,S Creighton,Jose Figueroa,Richard Ashcroft,Graham Hart,Valerie Delpech,Alison E Brown,Graeme Rooney,Maria Sampson,Adrian R. Martineau,Fern Terris-Prestholt,Chris Griffiths +20 more
TL;DR: Promotion of opt-out rapid testing in general practice led to increased rate of diagnosis, and might increase early detection, of HIV, and it is recommended implementation of HIV screening in general practices in areas with high HIV prevalence.
Journal ArticleDOI
A unique phosphatidylinositol 4-phosphate 5-kinase is activated by ADP-ribosylation factor in Plasmodium falciparum.
Werner Leber,Alison Skippen,Quinton L. Fivelman,Paul W. Bowyer,Shamshad Cockcroft,David A. Baker +5 more
TL;DR: The unexpected physical attachment of an NCS-like domain to the plasmodial PIP5K might reflect a unique functional link between the calcium and PtdIns(4,5)P(2) pathways allowing modulation of Ptd insurance production in response to changes in intracellular calcium concentrations within the parasite.
Journal ArticleDOI
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
Rebecca F. Baggaley,Michael A. Irvine,Michael A. Irvine,Werner Leber,Valentina Cambiano,Jose Figueroa,Heather McMullen,Jane Anderson,Andreia Santos,Fern Terris-Prestholt,Alec Miners,T. Déirdre Hollingsworth,Chris Griffiths +12 more
TL;DR: Screening for HIV in primary care is cost-effective and should be promoted, in settings where long-term health-care costs of late-diagnosed patients in high-prevalence regions are much higher (≥60%) than those of patients diagnosed earlier.
Journal ArticleDOI
Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2).
Werner Leber,Oliver Lammel,Andrea Siebenhofer,Andrea Siebenhofer,Monika Redlberger-Fritz,Jasmina Panovska-Griffiths,Jasmina Panovska-Griffiths,Thomas Czypionka +7 more
TL;DR: Czypionka et al. as mentioned in this paper showed that lateral flow testing (LFT) is an accurate alternative to RT-PCR testing in primary care in COVID-19 patients.